Description

(1-Oxo-5,6,7,8-Tetrahydro-1H-Phthalazin-2-Yl)-Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a distinct bicyclic heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular scaffolds. It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors for drug discovery and development programs.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug candidates, especially those targeting central nervous system (CNS) disorders, inflammation, or oncology.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and the generation of compound libraries for high-throughput screening.
• API Development: Used in the research and scale-up phases for developing new Active Pharmaceutical Ingredients (APIs) with phthalazine-based core structures.
• Bioconjugation & Probe Synthesis: The acetic acid moiety allows for further functionalization, making it suitable for creating biochemical probes or conjugated molecules for diagnostic applications.
• Contract Research & Manufacturing (CRAM): Supplied to CROs and CDMOs engaged in custom synthesis and process development for client projects.

Basic Information

Product Name	(1-Oxo-5,6,7,8-Tetrahydro-1H-Phthalazin-2-Yl)-Acetic Acid
CAS No.	1239746-66-7
Molecular Formula	C₁₀H₁₂N₂O₃
Molecular Weight	208.21 g/mol
Synonyms	2-(1-Oxo-5,6,7,8-tetrahydro-1H-phthalazin-2-yl)acetic acid; 2-(1-Oxo-5,6,7,8-tetrahydrophthalazin-2-yl)acetic acid; 1H-Phthalazin-2-ylacetic acid, 5,6,7,8-tetrahydro-1-oxo-; Tetrahydrophthalazinone acetic acid derivative; 1-Oxo-1,2,3,4-tetrahydrophthalazine-2-acetic acid; (1-Oxo-1,2,3,4-tetrahydrophthalazin-2-yl)acetic acid; 2-Carboxymethyl-5,6,7,8-tetrahydro-1-phthalazinone
EINECS	Contact for details

Quality Control

Our (1-Oxo-5,6,7,8-Tetrahydro-1H-Phthalazin-2-Yl)-Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical R&D and pre-clinical applications. Certificates of Analysis (COA) with detailed chromatographic data (HPLC) are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.